Glyxambi 10 mg/5 mg Tablets contain a combination of Empagliflozin 10 mg and Linagliptin 5 mg, two oral antidiabetic medicines used to help manage blood glucose levels in adults with Type 2 Diabetes Mellitus. Empagliflozin belongs to the SGLT2 inhibitor class and helps the kidneys remove excess glucose through urine, while Linagliptin is a DPP-4 inhibitor that helps increase insulin release and reduce glucagon secretion in response to meals. Glyxambi is generally used along with a healthy diet and regular physical activity when additional blood sugar control is required. The medicine should be taken exactly as prescribed by a qualified healthcare professional. It is not intended for the treatment of Type 1 diabetes or diabetic ketoacidosis. Composition: Empagliflozin 10 mg + Linagliptin 5 mg Dosage Form: Tablets Therapeutic Category: Antidiabetic Medicine Indication: Type 2 Diabetes Mellitus Patients should discuss their medical history, kidney function, other medications, and possible side effects with their healthcare professional before starting treatment.